fbpx

News

Lundbeckfonden news

Professor Hartwig Siebners: Brain stimulation to relieve symptoms of Parkinson’s disease   Hartwig Siebner’s project is receiving a grant of DKK 35 million from The Lundbeck Foundation Parkinson’s disease has a range of symptoms that have a pronounced impact on the patient’s quality of life – and these symptoms, for instance motor problems, can only...
Professor Martin Røssel Larsen: Mini-Brains to shed light on nervous disorders Martin Røssel Larsen’s project is receiving a grant of DKK 35 million from The Lundbeck Foundation When a foetus’s brain does not develop normally, it may mark the beginning of a brain disorder that will come to light later in life. However, it can...
Research Director Kasper Lage: Mechanisms of schizophrenia Kasper Lage’s project is receiving a grant of DKK 50 million from The Lundbeck Foundation Schizophrenia is caused by an extremely complex interaction between heredity and environment – between genetics and external influences. In reality, a gene is a recipe for a protein, and Kasper Lage aims to...
The Lundbeck Foundation awards grants worth DKK 120 million to three sophisticated brain research projects The funding goes to neuroscience research partnerships, and the projects aim to: develop new therapies for Parkinson’s disease; detect early-stage changes in the brain in connection with brain disorders; and increase our understanding of a range of genetic networks in...
Eske Willerslev receives prestigious Norwegian science prize for his Lundbeck Foundation research on brain disorders Professor Eske Willerslev, head of the Lundbeck Foundation GeoGenetics Centre at the University of Copenhagen, has received the Norwegian Olav Thon Foundation’s International Research Award 2021. This is a personal award – therefore, not earmarked for research – and it...
About the Lundbeck Foundation The Lundbeck Foundation’s (LF) supports neuroscience research to create new insights and knowledge about the brain that can lead to better prevention, diagnostic and treatment of brain diseases. In 2021, LF will take over a web-centred educational- and knowledge-focused platform, that has been developed by an international faculty of experts and...
About The Lundbeck Foundation In 2020, The Lundbeck Foundation (LF) initiated its new strategy ‘Bringing Discoveries to Lives’, which covers all aspects of the foundation’s activities from ownerships of three Danish healthcare companies, over investments in the biotech-sector in Denmark and globally, to grants to scientific research projects in healthcare with a particular focus on...
12. January – (Image: IO Biotech) The Lundbeck Foundation increases its commitment to IO Biotech as part of our 2030 strategy The Lundbeck Foundation is joining forces with IO Biotech’s other current owners, Novo Holdings and Sunstone, to invest in a major new Series B financing round in this immune-oncology specialist that is attracting significant...
The Lundbeck Foundation launches 2030 strategy with ambitious goals for grant and commercial activities December 22, 2020 With its strategy for 2030, “Bringing Discoveries to Lives”, the Lundbeck Foundation is embarking on a new chapter. A doubling of its wealth enables the Foundation to double its grants, with the aim of securing Denmark a top...
1 2 3 25

News

Brain stimulation to relieve symptoms of Parkinson’s disease
25. January 2021
Mini-Brains to shed light on nervous disorders
25. January 2021
Mechanisms of schizophrenia
25. January 2021

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge